Platelet function test may better gauge bleeding danger in ITP
An assessment of platelet function, rather than platelet counts alone, may better reflect bleeding severity and treatment response in people with immune thrombocytopenia (ITP),…
Steve Bryson PhD, —
Articles by Steve Bryson
In children with new ITP, Promacta works better than standard care
In a large, investigator-initiated clinical trial, about twice as many children and adolescents with newly diagnosed immune thrombocytopenia (ITP) achieved a sustained platelet response…
Platelet-boosting treatment curbs bleeding for ITP patients
Oral hetrombopag safely boosts platelet counts and reduces bleeding and the need for rescue therapy in adults with persistent immune thrombocytopenia (ITP) who have…
TTP in pregnancy boosts adverse maternal, fetal outcomes: Study
Pregnant women with thrombotic thrombocytopenic purpura (TTP) in the U.S. are nearly 20 times more likely to experience an adverse maternal outcome, according to…
Platelet transfusion tied to much higher risk of death in TTP: Study
Platelet transfusions more than double the risk of death among people with thrombotic thrombocytopenic purpura (TTP), according to a review of published studies.
AI predicts how kids with ITP will respond to rituximab infusion
Artificial intelligence (AI) can accurately predict a response to the second-line therapy rituximab in children and adolescents with immune thrombocytopenia (ITP), according to a…
